Welcome to our dedicated page for Innovative Eyewear SEC filings (Ticker: LUCY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Innovative Eyewear's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Innovative Eyewear's regulatory disclosures and financial reporting.
Innovative Eyewear Inc (LUCY) is the issuer for a planned resale of its common stock under Rule 144 by Joaquin Abondano, identified as an officer. The notice covers a potential sale of up to 14,800 shares of common stock, originally received as an RSU grant, with Raymond James & Associates acting as broker.
The filing also reports that Abondano sold 5,020 shares of Innovative Eyewear common stock during the past three months for total proceeds of 3,288.00. The sales are to be made for cash on Nasdaq.
Innovative Eyewear Inc (LUCY) reported that Chief Financial Officer Gayle Oswald received two grants of 16,233 shares of common stock on April 2, 2026 and August 19, 2026 at $0.00 per share. On the same respective dates, she sold 7,574 shares at a $1.0725 average price and 7,959 shares at a $0.6745 average price in open market or private transactions. The filing’s Rule 10b5-1 checkbox is not marked as being pursuant to a trading plan, and it does not state her total holdings after these transactions.
Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief AI & Growth Officer Konrad Dabrowski. He received grants of 20,900 shares of common stock on April 2, 2026 and August 19, 2026, each at no cost, and sold 6,692 shares on April 2 at $1.0581 per share and 6,935 shares on August 19 at a weighted-average price of $0.6911 per share in open-market or private transactions. Post-transaction holdings were not provided.
Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief Operating Officer Joaquin Abondano. On April 2 and August 19, 2026, he received two grants of 14,800 Common Shares each at $0.00 per share as awards. On the same dates, he sold 4,779 shares at $1.0501 per share and 5,020 shares at an average of $0.6765 per share in open-market or private transactions. The August 19 price is disclosed as a weighted average, with detailed trade breakdowns available on request. The filing states these transactions were not conducted under a Rule 10b5-1 trading plan.
Innovative Eyewear Inc (LUCY) reported that Chief Executive Officer and director Harrison R. Gross had both awards and sales of Common Stock. On April 2, 2026 and August 19, 2026, he received 24,600 shares on each date as a grant or award at $0.00 per share. On those same dates he sold shares in open market or private transactions, including 13,764 shares at an average price of $1.0658, 8,252 shares at an average price of $0.6916, and 5,722 shares at an average price of $0.705, with each price disclosed as a weighted average over multiple trades.
Innovative Eyewear Inc (LUCY) reported that Chief Technology Officer David Eric Cohen had a mix of stock grants and sales. On April 2 and August 19, 2026, he received 18,200 shares of common stock each time as grant/award acquisitions at $0.00 per share. Across April 2, April 9, July 6, and August 19, 2026, he sold a total of 15,769 shares of common stock in open-market or private transactions at per-share prices ranging from $1.0436–$1.17 and a weighted average price of $0.6802 for the August 19 sale.
Innovative Eyewear Inc (symbol LUCY) is the issuer for a notice of proposed sale of securities filed on behalf of officer David Eric Cohen under Rule 144. The notice covers a planned sale of up to 18,200 shares of common stock, expected on or about 08/19/2026, through Raymond James & Associates, Inc. The shares are described as originating from an RSU Grant by the issuer, with cash as the form of payment. The filing also reports that Cohen sold 1,860 shares of common stock on 07/06/2026 during the prior three months.
Innovative Eyewear Inc (LUCY) had a notice filed under Rule 144 for a planned sale of its common stock by officer Konrad Dabrowski. Up to 20,900 shares may be sold through Raymond James & Associates, Inc. on Nasdaq, with an aggregate market value of $14,839.00. The shares relate to an RSU Grant, and total common shares outstanding are listed as 6,403,728, a baseline figure rather than the amount being sold.
Innovative Eyewear Inc (LUCY) received a Rule 144 notice indicating that officer Harrison R. Gross plans to resell up to 24,600 shares of common stock. The shares relate to an RSU grant from the issuer and are expected to be sold for cash through Raymond James & Associates, Inc., with an approximate sale date of 08/19/2026.
Innovative Eyewear Inc (LUCY) has a notice of proposed sale of common stock filed on behalf of officer Joaquin Abondano under Rule 144. The notice lists a potential sale of 4,389 common shares through Raymond James & Associates, Inc., with an aggregate market value of $3,120.58 and 6,403,728 shares of common stock outstanding. The securities are tied to a 14,800-share RSU grant, with cash as the form of payment. Melissa Fisher signed as a duly authorized representative of Raymond James & Associates, Inc., acting as attorney-in-fact for Joaquin Abondano.